Border and imported bancroftian filariases: Baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 36, Issue 2, 2005, Pages 390-407

  Bhumiratana, Adisak ^a   Koyadun, Surachart ^b   Srisuphanunt, Mayuna ^a   Satitvipawee, Pratana ^a   Limpairojn, Nukool ^c   Gaewchaiyo, Gitipong ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c Army Institute of Pathology   (Thailand)

^d RAJAVITHI HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFILARIAL AGENT; DIETHYLCARBAMAZINE; FILADEC; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN; PARASITE ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANIMAL; ARTICLE; BLOOD; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG EFFECT; DRUG EFFICACY; ELEPHANTIASIS; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; FILARIASIS; GENDER; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INFECTION RATE; ISOLATION AND PURIFICATION; MAJOR CLINICAL STUDY; MALE; MYANMAR; PREVALENCE; SEROPREVALENCE; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SUPERINFECTION; THAILAND; WUCHERERIA BANCROFTI;

EID: 20444431531     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ambriose-Thomas P. Parasitic diseases and immunodeficiencies. Parasitology2001; 122 (suppl): S65-71.
2. Anonymous. WHO-SEAMEO TROPMED Workshop on lymphatic filariasis situation analysis and mapping in Mekong-plus countries, Bangkok: WHO SEAMEO TROPMED, 5-9 February 2001.
3. Anonymous. The meeting on development of health collaboration along Thailand-Myanmar border areas held at Lotus Hotel Pang Suan Kaew, Chiang Mai, Thailand, 18-19 March 2004.
4. Bhumiratana A. ICT Filariasis card test as direct assessment tool for evaluation of antigenaemia rate in communities endemic for Wuchereria bancrofti in Thailand. Mahidol J 2000; 7 (suppl): 17-23.
5. Bhumiratana A, Koyadun S, Suvannadabba S, et al. Field trial of the ICT Filariasis for diagnosis of Wuchereria bancrofti infections in an endemic population of Thailand. Southeast Asian J Trop Med Public Health 1999; 30: 562-8.
6. Bhumiratana A, Wattanakull B, Koyadun S, Suvannadabba S, Rojanapremsuk S, Tantiwattanasup W. Relationship between male hydrocele and infection prevalences in clustered communities with uncertain transmission of Wuchereria bancrofti on the Thailand-Myanmar border. Southeast Asian J Trop Med Public Health 2002; 33: 7-17.
7. Bundy DAP, Grenfell BT, Rajagopwlan PK. Immunoepidemiology of lymphatic filariasis: the relationship between infection and disease. Immunol Today 1991; 12: A71-5.
8. Chanteau S, Moulia-Pelat JP, Glaziou P, et al. Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis. J Infect Dis 1994; 170: 247-50.
9. CDC. Interpreatation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type I infection. MMWR 1989; 38 (suppl): S1-7.
10. CDC. CDC Model Performance Evaluation Program: Human immunodeficiency virus type 1 (HIV-1) antibody testing. Report of results for the performance evaluation survey conducted during January 2003. 2003: 1-23.
11. Communicable Disease Control Department (CDCD), Ministry of Public Health. Communicable disease control in Thailand 2000. Bangkok: Express Transportation Organization, 2001: 46-8.
12. Cox FEG. Concomitant infections, parasites and immune responses. Parasitology 2001; 122 (suppl): S23-38.
13. Filariasis Division, Communicable Disease Control Department, Ministry of Public Health. Lymphatic filariasis. Bangkok: War Veterans Organization. 1998: 1-54.
14. Filariasis Division, Communicable Disease Control Department, Ministry of Public Health. The National Program to Eliminate Lymphatic Filariasis by Fiscal Years 2002-2006. Bangkok: Amigo Studio, 2000: 1-35.
15. th National Plan for Social and Economic Development by fiscal years 2002-2006. Bangkok, 2-3 August 2001.
16. Flieder DB, Moran CA. Pulmonary dirofilariasis: a clinicopathologic study of 41 lesions in 39 patients. Human Pathol 1999; 30: 251-6.
17. Glickman LT, Grieve RB, Schantz PM. Serologic diagnosis of zoonotic pulmonary dirofilariasis. Am J Med 1986; 80: 161-5.
18. Grenfell BT, Micheal E. Infection and disease in lymphatic filariasis: an epidemiological approach. Parasitology 1992; 104 (suppl): S81-90.
19. Grenfell BT, Micheal E, Denham DA. A model for the dynamics of human lymphatic filariasis. Parasitol Today 1991; 7: 318-23.
20. Harinasuta C, Sucharit S, Deesin T, Surathin K, Vutikes S. Studies on the nocturnally subperiodic strain of Wuchereria bancrofti from West Thailand. Southeast Asian J Trop Med Public Health 1970a; 1: 152-8.
21. Harinasuta C, Sucharit S, Deesin T, Surathin K, Vutikes S. Bancroftian filariasis in Thailand, a new endemic area. Southeast Asian J Trop Med Public Health 1970b; 1: 233-9.
22. Itoh M, Weerasooriya MV, Gunawardena NK, Mudalige MP, Samarawickrema WA, Kimura E. Wuchereria bancrofti antigenaemia in Sri Lanka. Trop Med Int Health 1996; 1: 859-64.
23. Knapp RG, Miller MC. Clinical epidemiology and biostatistics. Maryland: Williams & Wilkins; 1992.
24. Koyadun S, Bhumiratana A, Prikchu P. Wuchereria bancrofti antigenemia clearance among Myanmar migrants after biannual mass treatments with diethylcarbamazine, 300 mg oral-dose FILADEC tablet, in Southern Thailand. Southeast Asian J Trop Med Public Health 2003; 34: 758-67.
25. Jelinek T. Human dirofilariasis. Int J Dermatol 1996; 35: 872-5.
26. McCarthy JS, Guinea A, Weil GJ, Ottesen EA. Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection. J Infect Dis 1995; 172: 521-6.
27. Mitchell GF. Co-evolution of pararsites and adaptive immune responses. Immunol Today 1991; 12: A2-5.
28. More SJ, Copeman DB. A highly specific and sensitive monoclonal antibody based ELISA for the detection of circulating antigenemia in bancroftian filariasis. Trop Med Parasitol 1990; 41: 403-6.
29. Ngugen NL, Plichart C, Esterre P. Assessment of immunochromatographic test for rapid lymphatic filariasis diagnosis. Parasite 1999; 6: 355-8.
30. Ottesen EA. Infection and disease in lymphatic filariasis: an immunological perspective. Parasitology 1992; 104 (suppl): S71-9.
31. Ottesen EA, Duke BOL, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull WHO 1997; 75: 491-503.
32. Ottesen EA, Ismail MM, Horton J. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 1999; 15: 382-6.
33. Omar MS, Sheikha AK, Al-Amari OM, Abdalla SE, Musa RA. Field evaluation of two diagnostic antigen tests for Wuchereria bancrofti infection among Indian expatriates in Saudi Arabia. Southeast Asian J Trop Med Public Health 2000; 31: 415-8.
34. Ong RKC, Doyle RL. Tropical pulmonary eosinophilia. Chest 1998; 113: 1673-9.
35. Pani SP, Hoti SL, Elango A, Yuvaraj J, Lall R, Ramaiah KD. Evaluation of the ICT whole blood antigen card test to detect infection due to nocturnally periodic Wuchereria bancrofti in South India. Trop Med Int Health 2000; 5: 359-63.
36. Ramzy RM, Helmy H, el-Lethy AS, et al. Field evaluation of a rapid format kit for the diagnosis of bancroftian filariasis in Egypt. East Mediterr Health J 2000; 5: 880-7.
37. Rocha A, Addiss D, Ribeiro ME, et al. Evaluation of the Og4C3 ELISA in Wuchereria bancrofti infection: infected persons with undetectable or ultra-low microfilarial densities. Trop Med Int Health 1996; 1: 859-64.
38. nd ed. Florida: Chapman & Hall/CRC; 2000.
39. Simonsen PE, Dunyo SK. Comparative evaluation of three new tools for diagnosis of bancroftian filariasis based on detection of specific circulating antigens. Trans R Soc Trop Med Hyg 1999; 93: 278-82.
40. Srividya A, Pani SP, Rajagopalan PK, Bundy DAP. Grenfell BT. The dynamics of infection and disease in Bancroftian filariasis. Trans R Soc Trop Med Hyg 1991; 85: 255-9.
41. Weber B, Gürtler L, Thorstensson R, et al. Multicenter evaluation of a new automated fouth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. J Clin Microbiol 2002; 40: 1938-46.
42. Weil GJ, Lammie PJ, Weiss N. The ICT Filariasis: a rapid format antigen test for diagnosis of bancroftian filariasis. Parasitol Today 1997; 13: 401-4.
43. Weil GJ, Liftis F. Identification and partial characterization of a parasite antigen in sera from humans infected with Wuchereria bancrofti. J Immunol 1987; 138: 3035-41.
44. WHO. Lymphatic filariasis: the disease and its control. Fifth Report of the WHO Expert Committee on Filariasis. Geneva: World Health Organization. WHO Tech Rep Ser 1992; 821: 1-71.
45. WHO. Lymphatic filariasis infection and disease: control strategies. Report of a consultative meeting held at the Universiti Sains Malaysia, Penang, Malaysia, 22-24 August 1994. Geneva: World Health Organization. WHO/TDR/CTD/FIL/PENANG/94.1. 1994.
46. WHO. Revised recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1997; 72: 81-7.
47. WHO. Informal consultation on epidemiologic approaches to lymphatic filariasis elimination: initial assessment, monitoring, and certification, Atlanta, Georgia, USA, 2-4 September 1998. Geneva: World Health Organization. WHO/FIL/99.195. 1999.
48. WHO. Elimination of lymphatic filariasis. Report of informal consultative meeting on lymphatic filaraisis in SEA region. Bhubaneswar, Orissa, India, 23-25 February 2000.
49. WHO. Regional strategic plan for elimination of lymphatic filariasis (2000-2004). New Delhi: WHO South-East Asia Regional Office. SEA/FIL/28.corr.1 2001.
50. WHO. Global program to eliminate lymphatic filariasis: Annual report on lymphatic filariasis 2001. Geneva: World Health Organization. WHO/CDS/CPE/CEE/2002.28. 2002.